In The News,
ADVI Director, Lindsay Bealor Greenleaf, discussed why including a drug’s list price in direct-to-consumer ads can be misleading to patients with The Daily Caller
[el-text]
Written by Evie Fordham
***excerpt***
“Simply disclosing a drug’s list price in advertisements can be misleading because list prices don’t reflect patients’ out-of-pocket costs, which vary from plan to plan,” Lindsay Bealor Greenleaf, Director of Policy at ADVI Health, told The Daily Caller News Foundation in a statement Friday.
***end excerpt***
[/el-text]